As for clinical trials of curcumin treatment for sepsis, one trial demonstrated that when a formulation of nano-curcumin was administered to septic patients in an intensive treatment unit, a marked decrease in inflammatory markers, like the erythrocyte sedimentation rate, IL-8, presepsin, and neutrophils, was observed [142]. The gene discussed is CXCL8; the disease is Sepsis.